Keyphrases
Localized Prostate Cancer
70%
New Jersey
69%
Prostate Cancer
39%
United States
33%
Surveillance Epidemiology
32%
Cancer Incidence
31%
Cancer Registry
29%
Functional Outcome
29%
Confidence Interval
29%
External Beam Radiotherapy
27%
Radical Prostatectomy
26%
Sexual Behavior
24%
Non-Hispanic White
24%
Colon Cancer
24%
Patient-reported Outcomes
23%
Cancer Pathology Reports
22%
Census Tract
21%
Cancer Survivors
20%
Race-ethnicity
20%
Comparative Effectiveness Analysis
19%
Cancer Genetics Risk Assessment
18%
Prostate Radiotherapy
18%
Urinary Function
17%
Hispanic
17%
Cervical Cancer
16%
Radiation Therapy
16%
State Cancer Registry
16%
In Cancer
16%
Residential History
15%
Class Imbalance
15%
Breast Cancer
14%
Socioeconomic Status
14%
Cancer Outcomes
13%
Survivors
13%
Low-dose-rate Brachytherapy
13%
Clinical Text Classification
13%
Cancer Disease
13%
Colon Cancer Survival
13%
Hepatocellular Carcinoma
13%
Brachytherapy Boost
13%
Invasive Cervical Cancer
13%
Working Diagnosis
13%
Cancer Care
13%
Colorectal Cancer
13%
Late-stage Diagnosis
12%
Adjusted Means
12%
Quality Measures
12%
Radiation Studies
12%
Radiotherapy
11%
Genetic Counseling
11%
Bowel Function
11%
Racial Disparities
11%
Breast Cancer Survivors
11%
Androgen Deprivation Therapy
10%
Population-based Study
10%
Utah
10%
Breast Cancer Mortality
10%
Odds Ratio
10%
Urinary Incontinence
10%
Expanded Prostate Cancer Index Composite
10%
Body Mass Index
10%
Active Surveillance
10%
Treatment Choice
9%
Risk Communication
9%
Embedded Counseling
9%
Neighborhood Socioeconomic Status
9%
Usual Care
9%
Hazard Ratio
9%
Breast Cancer Outcomes
9%
Randomized Controlled Trial
9%
Task Performance
9%
Poverty
9%
Childhood Cancer Survivors
9%
Comparative Effectiveness Studies
9%
Prostate Volume
9%
1-year Follow-up
9%
Enhanced Approach
9%
Rare Class
9%
Deep Learning Model
9%
Financial Burden
9%
Financial Toxicity
9%
Therapy Quality
9%
Cutaneous T-cell Lymphoma
9%
Prostate Disease
9%
Quality Metrics
9%
Cancer Stage at Diagnosis
9%
Area-based
9%
Older Adults
9%
Country of Origin
9%
Latinas
9%
Human Papillomavirus-associated Cancer
9%
Bootstrap Aggregation
9%
Privacy-preserving
9%
Hispanic Male
9%
Training Model
9%
Neighborhood Deprivation
8%
Multivariable
8%
Population-based
8%
Treatment Modalities
8%
Health-related Quality of Life
8%
Childhood Cancer
8%
Population-based Cancer Registry
8%
White People
8%
Stage at Diagnosis
8%
High Risk
8%
Medicaid
8%
Information Extraction
8%
Old Age
8%
Black Men
8%
Adjusted Odds Ratio
7%
Incidence Rate
7%
Unfavorable Prognosis
7%
Cancer Cases
7%
Quality of Care
7%
Deep Learning
7%
Machine Learning
7%
Clinically Significant Prostate Cancer
7%
Regional Stage
7%
Cancer Site
7%
End Results Program
7%
Randomized Trial
6%
Incidence Trends
6%
Regret
6%
Digital Pathology
6%
Informatics
6%
Bowel
6%
Prostate
6%
Clinically Significant
6%
Human Papillomavirus Vaccine
6%
Population-based Cohort
6%
Delayed Diagnosis
6%
Ovarian Cancer Survivors
6%
Cancer Mortality
6%
Residential Mobility
6%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
6%
Cancer Classification
6%
Socioeconomic Disparities
6%
Financial Hardship
6%
Demographic Characteristics
6%
Quality of Life Outcomes
6%
Irritative
6%
Cancer Treatment
6%
Female Breast Cancer
6%
Socioeconomic Factors
6%
Multi-task Cascaded Convolutional Neural Network (MTCNN)
6%
Knowledge Transfer
6%
Imbalanced Data
6%
Result-oriented
6%
Breast Cancer Risk
5%
Epidemiologic Studies
5%
Asian Americans
5%
Physical Disorder
5%
Risk Factors
5%
Diverse Populations
5%
Virtual Neighbors
5%
Treatment-related
5%
Leukemia
5%
Cancer Epidemiology
5%
Patient-reported Health
5%
Socio-environmental Factors
5%
Preliminary Estimates
5%
Early Breast Cancer
5%
Mammography Screening
5%
Clinical Data
5%
Favorable Prognosis
5%
Geographic Disparities
5%
Black Women
5%
Inclusion Criteria
5%
Brochure
5%
Age-adjusted
5%
Follow-up Care
5%
North America
5%
Insurance
5%
Ethnic Enclave
5%
Poor Outcome
5%
Relative Risk
5%
Medicine and Dentistry
Prostate Cancer
100%
Malignant Neoplasm
63%
Breast Cancer
54%
Diseases
38%
Cancer Registry
34%
Radiation Therapy
29%
Surveillance, Epidemiology, and End Results
28%
External Beam Radiotherapy
28%
Cancer Incidence
27%
Prostatectomy
25%
Urinary System
25%
Patient-Reported Outcome
23%
Cancer
22%
Cervical Cancer
22%
Odds Ratio
19%
Quality of Life
18%
Cancer Therapy
18%
Wart Virus
18%
Genetic Risk
18%
Colon Carcinoma
17%
Colorectal Carcinoma
17%
Hazard Ratio
14%
Cancer Genetics
14%
Low-Dose-Rate Brachytherapy
13%
Health Care Cost
12%
Childhood Cancer
12%
Counseling
12%
Logistic Regression Analysis
11%
Genetic Counseling
11%
Ovarian Cancer
11%
Intestine Function
10%
Socioeconomic Status
10%
Body Mass Index
10%
Risk Communication
9%
Randomized Controlled Trial
9%
Androgen Deprivation Therapy
9%
Adolescence
9%
Hepatocellular Carcinoma
9%
Ethnic Disparity
9%
Prostate Disease
9%
Effectiveness Study
9%
Financial Toxicity
9%
Cancer Survival
9%
Urine Incontinence
8%
Enuresis
8%
Health Care
8%
Colon Cancer Stage
7%
Pelvis
7%
Neoplasm
7%
Health Outcomes
7%
Cancer Localization
6%
Prostate Specific Antigen
6%
Lung Cancer
6%
Effect Size
6%
Prevalence
5%
Racial Disparity
5%
Primary Health Care
5%
Leukemia
5%
Recurrent Disease
5%
Cohort Effect
5%
Oropharynx Carcinoma
5%
Cancer Staging
5%
Cancer Diagnosis
5%
Cervical Cancer Screening
5%
Mediator
5%
Thyroid Cancer
5%
Surgery
5%